Document:

EX-10.24

 Exhibit 10.24 

MANAGEMENT SERVICES AGREEMENT 

This Management Services Agreement (the “Agreement”) dated June 8, 2015 is between Mattison Pathology, LLP d/b/a Avero
Diagnostics, a Texas limited liability partnership (the “Company”), and Avero Laboratory Holdings, LLC, a Delaware limited liability company (the “Management Company”). The Company and the Management Company are
collectively referred to herein as the “Parties”. 
 RECITALS 

A. The Company is engaged in the provision of professional medical services (the “Practice”) and operates practice sites (the
“Practice Sites”) in the State of Texas, and the Company’s physician employees and contractors (the “Physicians”) hold all licenses and permits necessary to practice medicine in the Applicable States in which
they practice medicine. 
 B. The Company desires to engage the Management Company to provide and arrange certain non-clinical management and administrative services. 
 AGREEMENT 

The Parties hereby agree as follows: 

ARTICLE I 
 ENGAGEMENT
AND AUTHORITY 
 1.1 Engagement of the Management Company. On the terms and subject to the conditions contained in this
Agreement, the Company hereby engages the Management Company, and the Management Company hereby accepts engagement by the Company, to provide and/or to arrange for the provision of the Management Services described in Article II and
Exhibit A to the Company. The Company expressly acknowledges that the Management Company may subcontract with third-parties for the performance of certain Management Services. 

1.2 Relationship of Parties. In performing their respective duties and obligations under this Agreement, the Parties are
independent contractors, and as such they will remain professionally and economically independent of each other. The Parties will not be deemed to be joint venturers, partners or employees of each other. For avoidance of doubt, the parties agree
that at all times relevant and pursuant to the terms and conditions of this Agreement, the Practices and their respective Physicians and other medical personnel are and will be construed to be practicing its and their profession independently, and
will not be deemed to be or construed to be an agent, servant or employee of the Management Company. 
 1.3 Conduct of Medical
Practice. The Company will be solely and exclusively in control of the provision of professional medical services, and the Management Company will neither have nor exercise any control or discretion over the methods by which the Physicians
practice medicine. Nothing in this Agreement will be construed to alter or otherwise affect the legal, ethical or professional relationships between and among the Company, the Physicians and 

 
their patients, nor does anything in this Agreement abrogate any right, privilege or obligation arising from or related to the physician-patient relationship. 

ARTICLE II 
 MANAGEMENT
SERVICES 
 2.1 General Authority. 

(a) The Management Company will provide or arrange for the provision of the non-clinical management
services set forth in Exhibit A (the “Management Services”) and the Management Company will be the Company’s exclusive provider of Management Services. Notwithstanding the foregoing, the Management Company will not
provide any service which would constitute the clinical practice of medicine or the provision of professional medical services. 
 (b) The
Company expressly authorizes the Management Company to perform the Management Services in the manner that the Management Company deems reasonably appropriate to meet the
day-to-day business needs of the Company, including the performance of specific business office functions at locations other than the Practice Sites. The Company will
not prevent the Management Company from providing, or causing to be provided, and the Management Company will provide or cause to be provided, the Management Services in a business-like manner and in compliance with (i) all applicable Laws,
(ii) all Orders by which the Parties are bound or to which the Parties are subject, and (iii) the standards, rules and regulations of the United States Department of Health and Human Services and any other federal, state or local
governmental agency or third-party payor exercising authority with respect to, accrediting, or providing reimbursement for, the Company or the Practice). 

2.2 Services the Management Company May Not Provide. The Management Company will not provide any of the following services to the
Company: assigning or designating clinical providers to treat patients; assuming responsibility for the care of patients; or engaging in any activity that involves the practice of medicine. 

ARTICLE III 
 GENERAL
OBLIGATIONS 
 3.1 Duty to Cooperate. The Parties acknowledge that mutual cooperation is critical to the performance of
their respective duties and obligations under this Agreement. To ensure the communication necessary for mutual cooperation, the Company will permit a representative designated by the Management Company (the “Management Company
Representative”) to attend and participate (in a non-voting capacity) in all meetings of the Company’s board of directors or other governing body and meetings of the Company’s equityholders
called pursuant to the Company Governing Documents or as otherwise required by applicable Law. The Company will give the Management Company at least five business days prior written notice of each such meeting, specifying the date, time and place of
the meeting and, if the meeting is a special meeting, the purposes for which the meeting is called. 

  
 2 

 3.2 Physicians. The Company will employ or engage all Physicians necessary to
conduct, manage and operate in a proper and efficient manner the medical practice conducted at the Practice Sites. 
 3.3 Business
Associate Provisions. The Management Company acknowledges and agrees that: the Company is a “covered entity” (as defined in the Administrative Simplification section of the Health Insurance Portability and Accountability Act of
1996, P.L. 104-191, and its implementing regulations (45 C.F.R. parts 160-164) (collectively “HIPAA”); and the Management Company is a “business
associate” (as defined under HIPAA) of the Company when the Management Company provides services to the Company involving “protected health information” (as defined under HIPAA) pursuant to this Agreement. The Management
Company agrees to perform all services involving protected health information in accordance with the Business Associate Provisions set forth on Exhibit B. 

3.4 Quantity, Service and Specialty Requirements; Standards. 

(a) The Management Company will periodically review, and make recommendations to the Company regarding, the appropriate number of full and
part-time Physicians needed by the Company to operate the Practice Sites (the “Physician Staffing Levels”). Final determinations with respect to the Physician Staffing Levels will at all times be the sole responsibility of the
Company. 
 (b) The Company, in consultation with the Management Company, will be responsible for (i) developing and implementing
utilization review and quality assurance guidelines (consistent with guidelines imposed by third-parties), (ii) supervising the Physicians’ submission to the Company of complete, accurate and timely documentation for coding and billing services
provided in the Practice, (iii) supervising the taking of corrective action by Physicians when Physicians do not satisfy guidelines and standards, (iv) credentialing of Physicians for the performance of specific procedures,
(v) handling impaired Physicians, and (vi) overseeing, developing and implementing policies of a purely medical nature (including medical records documentation, clinical communications with patients and the determination of resources to be
used for particular patients). 
 3.5 Employment and Independent Contractor Agreements. 

(a) The Company will employ each Physician who is or becomes an employee of the Company pursuant to a written employment agreement
substantially in a form prepared by the Management Company and approved by the Company (the “Employment Agreement”). The Company may not amend the form of Employment Agreement or the terms of any Physician’s employment without
the Management Company’s prior written approval, which consent shall not be unreasonably refused or conditioned. 
 (b) Except as
otherwise agreed by the Parties, the Company will engage each Physician who is or becomes an independent contractor of the Company pursuant to a written independent contractor agreement substantially in a form prepared by the Management Company and
approved by the Company (the “Independent Contractor Agreement”). The Company may not amend the form of Independent Contractor Agreement or the terms of any Physician’s 

  
 3 

 
independent contractor engagement without the Management Company’s prior written approval, which consent shall not be unreasonably refused or conditioned. 

3.6 Regulatory Matters. 

(a) The Physicians will be free, in their sole discretion, to exercise their professional judgment on behalf of patients of the Company.
Nothing in this Agreement permits the Management Company to affect or influence the professional judgment of any Physician. To the extent that any act or service required or permitted of the Management Company under any provision of this Agreement
is deemed to constitute the practice of medicine, the ownership or control of a medical practice or the operation of a clinic, such provision of this Agreement will be void ab initio and the performance of such act or service by the
Management Company will be deemed waived by the Company and the function will be performed by the Company. 
 (b) The Parties agree to
cooperate with one another in the fulfillment of their respective obligations under this Agreement, and to comply with (i) all Laws applicable to the Company and all Orders by which the Company is bound or to which the Company is subject
(including Laws and Orders relating to the practice of medicine, institutional and professional licensure, pharmacology and dispensing medicines or controlled substances, medical documentation, medical record retention, laboratory services,
unprofessional conduct, fee-splitting. referrals, billing and submission of false or fraudulent claims, claims processing, quality, safety, medical necessity, medical privacy and security, patient
confidentiality and informed consent and the hiring of employees or acquisition of services or supplies from Persons excluded from participation in government healthcare programs), and (ii) the requirements of any insurance company insuring the
Company or the Management Company against liability for injury or accident in or on the premises of the Company or the Practice. 

3.7 Books and Records. The Company will retain and provide the Management Company with full and unrestricted access to its books
and records (including work papers in the possession of its accountants) with respect to all transactions and the Company’s financial condition, assets, liabilities, operations and cash flows. 

3.8 Government Receivables Account. The Company shall establish and maintain a deposit account (the “Government
Receivables Account”) at a bank reasonably acceptable to the Management Company that is designated for the collection of any and all receivables payable by a governmental authority (including Medicare, Medicaid and any similar federal or
state program) (“Government Receivables”). The Company shall (A) deposit or cause to be deposited promptly, all cash, checks, drafts or other similar items of payment relating to or constituting payments made in respect of any
and all Government Receivables into the Government Receivables Account, (B) request in writing and otherwise take such reasonable steps to ensure that all payors of Government Receivables remit all payments of Government Receivables directly to
the Government Receivables Account and (C) shall not permit any other payments or receivables (other than Government Receivables) to be deposited into the Government Receivables Account. In the depositary agreement for the Government
Receivables Account with the bank (the “Depositary Agreement”), which Depositary Agreement shall be in form and substance reasonably satisfactory to the Management Company, the Company shall instruct the bank to “sweep”
daily into a bank account held by the Management Company the account 

  
 4 

 
balance in the Government Receivables Account. Such instructions to the bank may be revoked, rescinded or modified at the sole instruction of the Company. The Depositary Agreement, however, shall
provide that in the event that such instructions to the bank are in any way revoked, rescinded or modified, the bank shall notify the Management Company immediately. Additionally, the Management Company and the Company agree that the Company’s
revoking, rescinding or modifying such instructions to the bank shall constitute a material breach by the Company of this Agreement. The Company shall (A) deposit or cause to be deposited promptly all cash, checks, drafts or other similar items
of payment relating to or constituting receivables other than Government Receivables into the Management Company Account and (B) request in writing and otherwise take such reasonable steps to ensure that all account debtors remit all payments
of receivables other than Government Receivables into the Management Company Account. 
 ARTICLE IV 

FINANCIAL ARRANGEMENTS 

4.1 Practice Expenses. All Practice Expenses (as defined herein) attributable to periods after the date of this Agreement,
including the compensation of the Physicians, shall be the sole responsibility of the Practice and shall be paid by the Management Company or its designee as agent and on behalf of the Practice. Such expenses may include a portion of reasonable
corporate overhead of the Management Company allocable to the activities of the Practice, which shall be billed to the Practice at the actual cost to the Management Company. “Practice Expenses” means the following expenses, whether
incurred by the Practice or the Management Company: state and federal payroll taxes or self-employment taxes incurred by the Practice in connection with employment of the Physicians and other employees of the Practice, Physician compensation and
benefit expenses and compensation and benefit expenses for other employees of the Practice (both professional and non-professional), premiums for professional and general liability insurance, medical books and
journals, registration fees for continuing medical education, membership dues for professional organizations, locum tenens expenses, automobile and mileage expenses, facility leases, repairs and maintenance, telephones and pagers, utilities, billing
services, courier services, legal expenses, travel and entertainment, outside medical consultants, license fees, marketing, advertising, promotion, service of laboratory, laboratory and other equipment, all other reasonable overhead of the Practice,
all other expenses identified in this Agreement as Practice Expenses, all expenses identified in this Agreement as incurred by the Management Company on behalf of Practice, and other expenses approved from time to time by the Practice (in each case,
to the extent not provided by the Management Company under this Agreement). 
 4.2 Management Fee. 

(a) The Parties hereby agree and acknowledge that, in consideration for the Management Services performed hereunder, the Practice shall pay the
Management Company an annual management service fee equal to the revenues generated by the Practice for the preceding month in excess of the Practice Expenses for the same period (the “Management Fee”), payable in equal monthly
installments. The Management Fee is intended to provide the Management Company with fair market value payment commensurate with the services provided, its capital investment, use of its trade name and its expertise in laboratory and professional
practice 

  
 5 

 
management. The Practice hereby acknowledges and agrees that the Management Fee may be adjusted annually by the Management Company, based upon the Management Company’s reasonable estimate of
the Practice’s demand for Management Services in the following year. 
 (b) The Parties have determined the Management Fee to be equal
to the fair market value of the Management Services, without consideration of the proximity of the Company to any referral sources or the volume or value of any referrals from the Management Company or any of its Affiliates to the Company or from
the Company to the Management Company or any of its Affiliates, that is reimbursed under any governmental or private health care payment or insurance program. 

(c) Payment of the Fee to Management Company is not intended to be and shall not be interpreted or applied as permitting Management Company to
share in the Company’s fees for medical services. The Fee is acknowledged and agreed by the parties as being fair, equitable and reasonable in all respects and constituting fair market value for the substantial commitment of resources made by
Management Company under or in connection with this Agreement. The parties acknowledge and agree that the Fee set forth in this Agreement has been arrived at through arm’s length negotiations and is intended to compensate Management Company in
a manner that is commercially reasonable, consistent with fair market value. The Management Company shall neither have nor exercise any control or direction over the number, type or recipient of patient referrals made by the Company or its
Physicians and nothing in this Agreement shall be construed as directing or influencing such referrals. None of the Management Company’s activities contemplated under this Agreement, or otherwise, shall constitute obligations of the Management
Company to generate patient flow or business to the Practice. No benefits to the Practice or the Management Company under this Agreement require or are in any way contingent upon the admission, recommendation, referral or any other arrangement for
the provision of any item or service offered by the Management Company, the Company or the Practice or any of their respective affiliates. The Management Fee does not include any discount, rebate, kickback, or other reduction in charge. 

(d) The Management Company, as agent and on behalf of the Practice, shall utilize revenues of the Practice to pay accrued and then-payable
Practice Expenses prior to payment of the Management Fee. 
 4.3 Expense Reimbursement. The Company will reimburse the
Management Company for all reasonable expenses (including travel, meals and lodging expenses) incurred by the Management Company in connection with the provision of the Management Services. Remittances to Company of monies collected will be made net
of amounts for which the Management Company is then due to reimbursement from the Company pursuant to this Agreement. 
 4.4
Failure to Pay. The Company’s failure to pay any portion of the Management Fee or reimbursable expenses when due will be a material breach of this Agreement by the Company. 

  
 6 

 ARTICLE V 

TERM AND TERMINATION 

5.1 Initial Term; Automatic Renewals. The initial term of this Agreement commences on the date of this Agreement and ends on the
tenth anniversary of the date of this Agreement, subject to earlier termination in accordance with Section 5.2 (the “Initial Term” and, together with all Renewal Terms, the “Term”). After
the Initial Term, this Agreement will automatically renew for successive five-year terms (each a “Renewal Term”) unless (i) either Party delivers written notice to the other Party of its intent not to renew this Agreement at
least 90 days before the end of the Term or (ii) this Agreement is otherwise terminated in accordance with Section 5.2. 

5.2 Termination. This Agreement may be terminated during the Term: 

(a) by mutual agreement of the Parties; 

(b) by the Company immediately and without notice if the Management Company breaches this Agreement and fails to cure such breach within 45
days after receiving written notice from the Company describing in reasonable detail the nature of the breach; or 
 (c) by the Management
Company immediately and without notice if the Company breaches this Agreement and fails to cure such breach within 45 days after receiving written notice from the Management Company describing in reasonable detail the nature of the breach. 

5.3 Effect of Expiration or Termination. 

(a) The expiration or termination of this Agreement in accordance with Section 5.2 will automatically relieve and
release each Party from the executory portion of such Party’s obligations under this Agreement; provided, however, that all obligations expressly extended beyond the Term by the terms of this Agreement (including this Article V,
Article VI, Article VII and Article IX) will survive the expiration or termination of this Agreement. 
 (b) Promptly (but in any
event within 10 days) after the expiration or termination of this Agreement, the Company will, and will cause its Affiliates, directors, managers, officers, equityholders, employees, agents, successors and permitted assigns to, either return to the
Company or destroy, delete or erase all written, electronic or other tangible forms of Confidential Information as required under Section 6.2. 

(c) Promptly (but in any event within 10 days) after the termination or expiration of this Agreement, the Company will pay to the Management
Company all Management Fees earned or accrued under this Agreement through the termination date, reimburse all reimbursable expenses incurred before the termination date and repay all Advances funded before the termination date; provided,
however, that if the Management Company terminates this Agreement pursuant to Section 5.2(c) or the Company terminates this Agreement in breach of this Agreement, then such payment will include the immediate payment of
all Management Fees owed to the Management Company for the remainder of the Term. 

  
 7 

 (d) After the expiration or termination of this Agreement, the Company will retain and
provide the Management Company with full and unrestricted access to its books and records (including work papers in the possession of its accountants) with respect to all transactions and the Company’s financial condition, assets, liabilities,
operations and cash flows during the Term. 
 ARTICLE VI 

RESTRICTIVE COVENANTS 

6.1 Restrictive Covenants. In the course of receiving the Management Services, the Company will have access to the most
sensitive and most valuable trade secrets, proprietary information and other confidential information, including management reports, marketing studies, marketing plans, business plans, financial statements, feasibility studies, financial, accounting
and statistical data, price and cost information, customer lists, contracts, policies and procedures, internal memoranda, reports and other materials or records of a proprietary or confidential nature (collectively, “Confidential
Information”) of the Management Company, which constitute valuable business assets of the Management Company and its Affiliates, and the use, application or disclosure of such Confidential Information will cause substantial and possibly
irreparable damage to the business and asset value of the Management Company. Therefore, as an inducement for the Management Company to enter into this Agreement and to protect the Confidential Information and other business interests of the
Management Company, the Company agrees to be bound by the restrictive covenants contained in this Article VI. 
 6.2
Disclosure of Confidential Information. After the date of this Agreement, the Company will, and will cause its Affiliates, directors, managers, officers, equityholders, employees, agents, successors and permitted assigns to, keep confidential
and not disclose to any other Person or use for their own benefit or the benefit of any other Person any Confidential Information; provided, however, that the obligations under this Section 6.2 will not apply to Confidential Information
that (i) is or becomes generally available to the public without breach of the commitments contemplated by this Section 6.2, (ii) was available to the Company or its Affiliates, directors, managers, officers, equityholders, employees or
agents on a non-confidential basis before the date of this Agreement or (iii) is required to be disclosed by any Law or Order; provided that as soon as practicable before such disclosure, the
Company gives the Management Company prompt written notice of such disclosure to enable the Management Company to seek a protective order or otherwise preserve the confidentiality of such information. Promptly after the expiration or termination of
this Agreement, the Company will, and will cause its Affiliates, directors, managers, officers, equityholders, employees, agents, successors and permitted assigns to, (i) either return to the Company or destroy, delete or erase (with written
certification of such destruction, deletion or erasure provided to the Management Company by the Company) all written, electronic or other tangible forms of Confidential Information. After the expiration or termination of this Agreement, the Company
will not, and will cause its Affiliates, directors, managers, officers, equityholders, employees, agents, successors and permitted assigns not to, retain any copies, summaries, analyses, compilations, reports, extracts or other materials containing
or derived from any Confidential Information. Notwithstanding such return, destruction, deletion or erasure, all oral Confidential Information and the information embodied in all written Confidential Information will continue to be held confidential
pursuant to the terms of this Section 6.2. 

  
 8 

 6.3 Covenant Not to Solicit. Until the second anniversary of the expiration or
termination of this Agreement, the Company will not, directly or indirectly: 
 (a) solicit or induce or attempt to solicit or induce
(including by recruiting, interviewing or identifying or targeting as a candidate for recruitment) any director, limited liability company manager, partner, officer, employee, independent contractor or other agent of the Management Company or any of
its Affiliates (including the other professional practice groups to which the Management Company provides business, administrative and back office services) other than the Company (collectively, the “Company Group”)), who is acting
in such capacity or acted in such capacity at any time within the 12-month period immediately preceding the date of such solicitation, inducement or attempt, (a “Business Associate”) to
terminate, restrict or hinder such Business Associate’s association with any Company Group entity or interfere in any way with the relationship between such Business Associate and any Company Group; provided, however, that after the
termination or expiration of this Agreement, general solicitations published in a journal, newspaper or other publication or posted on an internet job site and not specifically directed toward Business Associates will not constitute a breach of the
covenants in this Section 6.3(a); 
 (b) hire or otherwise retain the services of any Business Associate as
equityholder, director, limited liability company manager, partner, officer, employee, independent contractor, licensee, consultant, advisor, agent or in any other capacity, or attempt or assist anyone else to do so; or 

(c) interfere with the relationship between any Company Group entity and any Person who is a supplier, lessor, lessee, dealer, distributor,
licensor, licensee, proprietor, partner, joint venturer, investor, lender, consultant, agent, customer, patient, physician referral source or any other Person having a business relationship with the Company Group, or attempt or assist anyone else to
do so. 
 6.4 Non-Disparagement. After the date of this Agreement, the Company will
not, directly or indirectly, make any disparaging, derogatory, negative or knowingly false statement about any Company Group entity or any of their respective directors, managers, officers, equityholders, employees, agents (including the Management
Company Representative), successors and permitted assigns, or any of their respective businesses, operations, financial condition or prospects, except as required by applicable Law or Order. 

6.5 Scope of Covenants; Equitable Relief. The Company acknowledges and agrees that (i) the restrictive covenants contained
in this Article VI and the territorial, time, activity and other limitations set forth herein are commercially reasonable and do not impose a greater restraint than is necessary to protect the goodwill and legitimate business interests of the
Company Group and its businesses, (ii) any breach of the restrictive covenants in this Article VI will cause irreparable injury to the Company Group and that actual damages may be difficult to ascertain and would be inadequate, and
(iii) if any breach of any such covenant occurs, then the Management Company will be entitled to injunctive relief in addition to such other legal and equitable remedies that may be available (without limiting the availability of legal or
equitable, including injunctive, remedies under any other provisions of this Agreement), and (iv) the 

  
 9 

 
Company hereby waives the claim or defense that an adequate remedy at law exists for such a breach. 

6.6 Equitable Tolling. If the Company breaches any covenant in this Article VI, then the duration of such covenant will be
tolled for a period of time equal to the time of such breach and, if the Management Company seeks injunctive relief or other remedies for any such breach, then the duration of such covenant will be tolled for a period of time equal to the pendency
of such proceedings (including all appeals). 
 ARTICLE VII 

INDEMNIFICATION 

7.1 Indemnification. The Company will indemnify, defend and hold harmless the Management Company, its Affiliates and their
respective directors, managers, officers, equityholders, employees, agents (including the Management Company Representative), successors and permitted assign (collectively, the “Management Company Indemnified Parties”) from and
against all losses, liabilities, demands, claims, actions or causes of action, regulatory, legislative or judicial proceedings or investigations, assessments, levies, fines, penalties, damages, costs and expenses (including reasonable
attorneys’, accountants’, investigators’ and experts’ fees and expenses) incurred in connection with the defense or investigation of any claim (“Damages”) sustained or incurred by any Management Company
Indemnified Party arising from or related to illegal activity, intentional misconduct, negligence (including, but not limited to, the malpractice or malfeasances of the Physicians) or breach of this Agreement by the Company or any of its employees
or contractors. 
 7.2 Cooperation and Settlement. The Company and the Management Company will coordinate the defense and
settlement of actions in which they are named. The Company will not settle an action in which both are named, unless the Management Company agrees to the terms and conditions of the settlement. 

7.3 Advancement of Expenses. During the pendency of any suit, action or proceeding with respect to which the Management Company
is entitled to indemnification under this Article VII, the Company will pay or reimburse the Management Company for reasonable defense expenses incurred in advance of final disposition of such suit, action or proceeding. If the Management
Company ultimately is not entitled to indemnification under this Article VII, then the Management Company will promptly repay to the Company the full amount of all such expenses paid or reimbursed by the Company. 

7.4 Other Remedies. The provisions of this Article VII are in addition to, and not in derogation of, any statutory,
equitable or common law remedies that the Management Company may have with respect to this Agreement or the subject matter of this Agreement. 

7.5 Survival. The Company’s indemnification obligations under this Article VII will survive the termination or
expiration of this Agreement. 

  
 10 

 ARTICLE VIII 

DEFINITIONS 
 For purposes
of this Agreement, the following terms have the following meanings: 
 “Affiliate” means, with respect to a particular
Person, (i) any other Person that, directly or indirectly, controls, is controlled by or is under common control with such Person, and (ii) any of such Person’s spouse, siblings (by law or marriage), ancestors and decedents and
(iii) any trust for the primary benefit of such Person or any of the foregoing. The term “control” means possession, direct or indirect, of the power to direct or cause the direction of the management and policies of another Person,
whether through the ownership of voting securities or equity interests, by contract or otherwise. 
 “Business Day” means a
day that is not a Saturday, Sunday or legal holiday on which banks are authorized or required to be closed in New York, New York. 

“Law” means any federal, state, local, municipal, foreign, international, multinational or other constitution, statute, law,
rule, regulation, ordinance, code, principle of common law or treaty. 
 “Order” means any order, injunction, judgment,
decree, ruling, assessment or arbitration award of any governmental authority or arbitrator. 
 “Person” means any natural
individual, corporation, partnership, limited liability company, joint venture, association, bank, trust company, trust or other entity, whether or not legal entities, or any governmental entity, agency or political subdivision. 

ARTICLE IX 
 GENERAL
PROVISIONS 
 9.1 Practice of Medicine. Nothing in this Agreement will be interpreted as prohibiting the Company or any
Physician from (a) obtaining or maintaining membership on the medical staff of any hospital or health care provider, (b) obtaining or maintaining clinical privileges at any hospital or health care provider, or (c) referring patients
to any hospital or health care provider. 
 9.2 Force Majeure. Neither Party will be liable for any failure or inability to
perform, or delay in performing, such Party’s obligations under this Agreement if such failure, inability or delay arises from an extraordinary cause beyond the reasonable control of the non-performing
Party; provided that such Party diligently and in good faith attempts to cure such non-performance as promptly as practicable. 

9.3 Notices. All notices and other communications required or permitted under this Agreement (a) must be in writing,
(b) will be duly given (i) when delivered personally to the recipient, (ii) one Business Day after being sent to the recipient by nationally recognized overnight private carrier (charges prepaid), or (iii) four Business Days
after being mailed to the recipient by certified or registered mail (postage prepaid and return receipt requested), and (c) addressed as follows (as applicable): 

  
 11 

 
			
	To Company:
		
		  	Mattison Pathology LLP d/b/a Avero Diagnostics
		  	6221 Riverside Drive, Suite 119
		  	Irving, TX 75039
	
	To the Management Company:
		
		  	c/o Progenity, Inc.
		  	4330 La Jolla Village Drive, Suite 200
		  	San Diego, CA 92122
		  	Attention: CFO with cc to : General Counsel

 or to such other respective address as each Party may designate by notice given in accordance with this
Section 9.3. 
 9.4 Entire Agreement. This Agreement constitutes the complete agreement and understanding among the
Parties regarding the subject matter of this Agreement and supersedes any prior understandings, agreements or representations regarding the subject matter of this Agreement. 

9.5 Amendments. The Parties may amend this Agreement only pursuant to a written agreement executed by the Parties. 

9.6 Non-Waiver. The Parties’ respective rights and remedies under this Agreement are
cumulative and not alternative. Neither the failure nor any delay by any Party in exercising any right, power or privilege under this Agreement will operate as a waiver of such right, power or privilege, and no single or partial exercise of any such
right, power or privilege will preclude any other or further exercise of such right, power or privilege or the exercise of any other right, power or privilege. No waiver will be effective unless it is in writing and signed by an authorized
representative of the waiving Party. No waiver given will be applicable except in the specific instance for which it was given. No notice to or demand on a Party will constitute a waiver of any obligation of such Party or the right of the Party
giving such notice or demand to take further action without notice or demand as provided in this Agreement. 
 9.7 Assignment.
The Company may not assign this Agreement or any rights under this Agreement, or delegate any duties under this Agreement, without the Management Company’s prior written consent. The Management Company may freely assign this Agreement or any
rights under this Agreement, or delegate any duties under this Agreement without the Company’s consent, including without limitation to any of its lenders as collateral security, and the Company shall cooperate with any such assignment by
executing such documents in connection therewith as shall be reasonably be required. 
 9.8 Binding Effect; Benefit. This
Agreement will inure to the benefit of and bind the Parties and their respective successors and permitted assigns. Nothing in this Agreement, express or implied, may be construed to give any Person other than the Parties and their respective
successors and permitted assigns any right, remedy, claim, obligation or liability arising from or 

  
 12 

 
related to this Agreement. This Agreement and all of its provisions and conditions are for the sole and exclusive benefit of the Parties and their respective successors and permitted assigns.

 9.9 Severability. If any court of competent jurisdiction holds any provision of this Agreement invalid or unenforceable,
then the other provisions of this Agreement will remain in full force and effect. Any provision of this Agreement held invalid or unenforceable only in part or degree will remain in full force and effect to the extent not held invalid or
unenforceable. 
 9.10 References. The headings of Sections are provided for convenience only and will not affect the
construction or interpretation of this Agreement. Unless otherwise provided, references to “Section(s)” and “Exhibit(s)” refer to the corresponding section(s) and exhibit(s) of this Agreement. Reference to a statute refers to the
statute, any amendments or successor legislation and all rules and regulations promulgated under or implementing the statute, as in effect at the relevant time. Reference to a contract, instrument or other document as of a given date means the
contract, instrument or other document as amended, supplemented and modified from time to time through such date. 
 9.11
Construction. Each Party participated in the negotiation and drafting of this Agreement, assisted by such legal and tax counsel as it desired, and contributed to its revisions. Any ambiguities with respect to any provision of this Agreement
will be construed fairly as to all Parties and not in favor of or against any Party. All pronouns and any variation thereof will be construed to refer to such gender and number as the identity of the subject may require. The terms
“include” and “including” indicate examples of a predicate word or clause and not a limitation on that word or clause. 

9.12 Governing Law. THIS AGREEMENT IS GOVERNED BY THE LAWS OF THE STATE OF TEXAS, WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES.

 9.13 Consent to Jurisdiction. Each party hereby irrevocably consents to the exclusive jurisdiction of the state and federal
courts of the State of Texas and irrevocably agrees that all actions or proceedings relating to this Agreement shall be litigated in such courts. Each party waives any objection which it may have based on lack of personal jurisdiction, improper
venue or forum non conveniens to the conduct of any proceeding in any such court and waives personal service of any and all process upon them. 

9.14 Waiver of Trial by Jury. EACH PARTY HEREBY WAIVES ITS RIGHT TO A JURY TRIAL IN CONNECTION WITH ANY SUIT, ACTION OR
PROCEEDING IN CONNECTION WITH ANY MATTER RELATING TO THIS AGREEMENT. 
 9.15 Counterparts. The Parties may execute this
Agreement in multiple counterparts, each of which will constitute an original and all of which, when taken together, will constitute one and the same agreement. The Parties may deliver executed signature pages to this Agreement by facsimile or e-mail transmission. No Party may raise as a defense to the formation or enforceability of this Agreement, and each Party forever waives any such defense, either (a) the use of a facsimile or email transmission
to deliver a signature or (b) the fact that any signature was signed and subsequently transmitted by facsimile or email transmission. 

[Signatures on the following page] 

  
 13 

 IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be duly executed as of the date first
above written. 
  

			
	MANAGEMENT COMPANY:
	
	AVERO LABORATORY HOLDINGS, LLC 
		
	By:	 	 /s/ Harry Stylli

		 	Harry Stylli
		 	Executive Chairman
	
	COMPANY:
	
	MATTISON PATHOLOGY, LLP
		
	By:	 	 /s/ John C. Mazzei

	Name:	 	John C. Mazzei
	Title:	 	C.E.O.

 [Signature Page to Management Agreement] 

 EXHIBIT A 

MANAGEMENT SERVICES 
 The Management
Services include the following: 
 1. The Management Company will provide or obtain for the Company the following legal services: 

(a) maintenance of all filings, licenses, permits, notices and other approvals required of the Company under applicable Laws and Orders
for the operation of the Practice; 
 (b) regulatory compliance counseling and oversight of audits, investigations and accreditation
processes; 
 (c) regulatory compliance counseling; 

(d) risk management and education; 

(e) professional liability and other insurance consulting; and 

(f) assistance in responding to demands for payment, allegations of liability and lawsuits. 

2. The Management Company will provide or obtain for the Company the following financial services: 

(a) general accounting services and maintenance of accounting books; 

(b) preparation of monthly and annual profit and loss statements, income statements and other financial statements; 

(c) preparation and processing of client invoices, receivables and payables and the management of receipts; 

(d) assistance in the handling and preparation of payroll and payroll tax-related statements and
documents (including completion of K-1, W-2, and 1099 forms); 

(e) preparation of tax returns and other tax forms for the Company and its medical director(s), as necessary; 

(f) processing of expense accounts for the Company’s employees (including IRS compliance and related services); 

(g) assistance with cash management, bank reconciliation and banking relations (including establishing bank accounts for the sole use
and benefit of the Company); 
 (h) management of the lockbox and deposit functions; 

 (i) assistance with budget preparation and services; and 

(j) assistance with the administration of Physician and employee bonus plans. 

3. The Management Company will provide all administrative personnel reasonably necessary to manage the business and administrative
aspects of the Practice and manage all decisions regarding work assignments, scheduling, hiring, firing and disciplining of administrative personnel and determinations of compensation levels and other terms of employment or engagement for all
administrative personnel (including determinations of salaries, wages, bonuses, fringe benefits, retirement benefits and health, disability and workers’ compensation insurance). 

4. The Management Company will provide or obtain for the Company the following human resources services for non-Physician personnel: 
 (a) development, administration and provision of guidance regarding
employment policies and procedures; provided that all policies and procedures governing Physicians and allied health professionals working at the Practices shall be adopted in the sole discretion of the Company and/or approved by the Company. 

(b) preparation of employment agreements for non-Physician employees; 

(c) background checks and verification; 

(d) orientation, fob, database entry and computer access to new employees; 

(e) benefit enrollment, administration and process management services; 

(f) implementation of workers compensation, equal employment opportunity and other employment-related regulatory requirements; and 

(g) coordination of the Company site administrative assistants. 

5. The Management Company will provide or obtain for the Company the following human resources and other services for Physicians: 

(a) preparation of employment agreements for Physician employees; 

(b) assistance with the preparation of new Physician welcome packets; 

(c) provision of software education services for Physicians; 

(d) maintenance of a Physician database; and 

(e) assistance with the development and production of printed communications intended for physicians and patients. 

6. The Management Company will provide or obtain for the Company the following information management services: 

 (a) management, maintenance and administration of hardware/software programs,
databases and interfaces; 
 (b) communications resources and internet client connections; 

(c) management of information technology service connections, security and connectivity maintenance; 

(d) management of outside hardware and software vendor maintenance; 

(e) planning and evaluation of new technology; 

(f) design, management and integration of web sites; 

(g) access to document copying and scanning interfaces; 

(h) emergency power and database back-up; and 

(i) development and production of printed materials for external marketing purposes (subject to the Company’s approval). 

7. The Management Company will provide or obtain for the Company the following collection services for the Company’s patient
accounts (“Patients Accounts”): 
 (a) receipt, crediting, depositing and recording payment of invoices for professional
services (in cash, check, money order or wire transfer) into the Company’s bank account (“Company Account”) in accordance with the Management Company’s procedures; and 

(b) negotiate compromises and settlements of patient accounts with patients or other responsible parties. 

8. The Management Company will provide or obtain for the Company the following billing services for the professional services rendered
by Physicians and other health care professionals employed by or under contract with the Company (collectively, “Professionals”): 

(a) review of incoming patient care forms to verify the accuracy and completeness of information required for billing purposes; 

(b) editing the Company’s patient care and charge collection forms as necessary to ensure that the Company collects information
necessary to submit claims for professional services; 
 (c) review, as appropriate, of the coding submitted by Professionals for
purposes of billing, consistent with applicable Laws, the billing and coding requirements under any contracts between the Company and third-party payors and/or as required by applicable third-party payor rules and procedures; 

(d) preparation and submission to patients, primary and secondary third-party payors and other persons responsible for payment for
professional services of the Physicians, all 

 
claims and patient invoices for payment for the professional services in the name and under the provider number of the Company engaging the Physicians or, if required by the third-party payor,
the provider number of the Physicians rendering or supervising the professional service; 
 (e) issuing, with respect to patient
invoices, monthly invoices before instituting collection procedures, the last of which will incorporate an overdue, pre-collection notice (unless other procedures are required to comply with applicable Law or
third-party payor requirements); 
 (f) reference of any unpaid patient account to debt collection agencies (which may, but need not
be, affiliates of the Management Company), with all necessary supporting documentation, or to a collection attorney (whose services would be provided at an additional cost not included in the Management Fees); 

(g) receipt and response to telephone communications and written or electronic correspondence received from patients with reference to
invoices; 
 (h) appeals, corrections and rebilling, in the Management Company’s commercially reasonable discretion, of claims
for reimbursement filed by the Management Company with any third-party payor that are denied or disputed by such third-party payor; 

(i) claim adjudication of disputed claims and resolution of outstanding billing events with third party payors; 

(j) receipt, crediting, depositing and recording payment of invoices and claims for professional services (in cash, check, money order
or wire transfer) into the Company Account in accordance with the Management Company’s procedures; 
 (k) reconciliation of all
bank deposits and deposit records; 
 (l) review of accounts receivable of the Company to determine the status of patient accounts
(i.e., current or delinquent), adjustment of account balances for partial payments received during the preceding month and correction of entries when required; 

(m) process, issuance, mailing and recording of checks or electronic funds transfers for refunds due on patient accounts; 

(n) maintenance of professional fee schedule entries and creation and maintenance of physician fee schedules in the Management
Company’s practice management system; 
 (o) administration of database/payor interfaces, maintenance of patient account history,
interaction with third-party payors for resolution of accounts (including eligibility inquiry, claim submission, status inquiry and appeals); 

(p) PR write off processing; administration of patient public relations and complaint processes (including account review, appeal and
adjustment of patient balances); 

 (q) assistance in the negotiation, on behalf of the Company, of provider agreements
with third-party payors and management, on behalf of the Company, of such contracts and relationships; 
 (r) Physician documentation
and coding guidance upon the reasonable request of the Company or in response to changes to applicable Laws, CPT codes or third-party payor rules; 

(s) billing, coding and compliance education to newly-hired Physicians and conduct of follow-up
chart audits and reviews of patient documentation for such Physicians consistent with past practice; 
 (t) conduct of Physician chart
audits when the Management Company has evidence of recurring non-compliance with applicable coding, documentation or billing Laws or third-party payor rules or when reasonably requested by the Company; and

 (u) preparation of provider enrollment, reassignment of benefits and credentialing applications and forms required by governmental
and nongovernmental third-party payors. 
 9. The Management Company will assist the Company in administering its relationships with
Physicians, including consulting with the Company as to performance standards, reviewing and proposing changes to the Company’s standard employment and independent contractor agreements, participating in deliberations as to appropriate
Physician Staffing Levels, reviewing staffing and coverage schedules, and, in consultation with the Company, recruiting additional Physicians. The Management Company will recommend Physician compensation models and determine Physician base and
incentive compensation, with the approval of the Company. 
 10. The Management Company, on behalf of the Company and/or individual
Physicians, as appropriate, will negotiate all agreements between the Company and/or such Physicians and third-parties for the provision of professional services that may be necessary or appropriate for the proper and efficient operation of the
Practice. 
 11. The Management Company, on behalf of the Company, will negotiate all agreements between the Company and its clients;
provided, however, that the Company shall retain the exclusive authority to determine the parameters of the Company’s contractual relationship with clients and third party private and government payors. 

12. The Management Company, on behalf of the Company, will negotiate and arrange for all medical and administrative office space, with
all leases and other office arrangements executed and delivered by the Management Company in its name. 
 13. The Management Company,
on behalf of the Company, will acquire for the benefit of the Company all leasehold improvements and furniture, fixtures and equipment reasonably necessary for the operation of the Practice and repair, maintain and replace such furniture, fixtures
and equipment necessitated by the negligence of the Company or any 

 
Physician. Title to the Equipment and other capital assets acquired by the Management Company for the benefit of the Practice will be in the name of the Management Company. 

14. The Management Company will supervise the Company’s continuous efforts to create, update, maintain and store all files and
records relating to the operation of the Practice, including accounting, billing, patient medical records and collection records. 

15. The Management Company will purchase, for the account of the Company, all administrative support services reasonably required for
the day-to-day operation of the Practice (including all utilities, laundry, janitorial and cleaning, security, printing, postage, coping, telephone and internet
services) and all supplies that are reasonably necessary for the day-to-day operation of the Practice. 

16. The Management Company will confer with the Company regarding the acquisition of medical equipment, instruments, medical fixtures,
office equipment, telephones, computers, office furniture and supplies that the Management Company determines to be necessary or appropriate for the proper and efficient operation of the Practice. 

17. The Management Company will manage equipment installation, testing and maintenance for the Company. 

18. The Management Company will assist the Company in obtaining insurance policies required or appropriate to protect the financial
interest of the Company and the Physicians, and assist the Company will establishing risk compliance, loss prevention and risk management functions. 

19. The Management Company will provide additional legal management, financial management, human resource-related, billing and
collection-related and information technology-related services at Company’s reasonable request and if necessary or appropriate for the proper management and administration of the Company; provided, however, that the Company will
compensate the Management Company for the performance of such additional services at pre-determined, mutually-agreed-upon rate reflecting the fair market value of such additional services, all of which the
Parties will set forth in a written amendment of this Agreement. 
 20. The Management Company will assist the Company with purchasing
advertising and marketing services for programs established by the Company by providing administrative support and consultation. 

 EXHIBIT B 

BUSINESS ASSOCIATE PROVISIONS 

The Management Company will perform any Management Services involving Protected Health Information received from, or created or received by
the Management Company on behalf of the Company (“PHI”), in accordance with the following Business Associate Provisions. 
 1.
General Provisions. 
 (a) Effect. To the extent that the Management Company receives PHI to perform Business Associate
activities, the terms and provisions of this Exhibit B supersede all conflicting or inconsistent terms and provisions of this Agreement to the extent of such conflict or inconsistency. 

(b) Capitalized Terms. Capitalized terms used in this Exhibit B without definition in this Agreement (including this
Exhibit B) are defined in the administrative simplification section of the Health Insurance Portability and Accountability Act of 1996 and its implementing regulations as amended by HITECH (defined below) (collectively,
“HIPAA”). 
 (c) No Third Party Beneficiaries. The Parties have not created and do not intend to create by
this Agreement any third party rights (including third party rights for Patients). 
 (d) Amendments. The Parties acknowledge
that the Health Information Technology for Economic and Clinical Health Act and its implementing regulations (collectively, “HITECH”) impose new requirements with respect to privacy, security and breach notification and contemplates
that such requirements will be implemented by regulations to be adopted by HHS. The HITECH provisions applicable to business associates (as defined under HIPAA) will be collectively referred to as the “HITECH BA Provisions”. A
HITECH BA Provision is effective on the later of (i) the date of this Agreement and (ii) the date specified in HITECH. 
 2.
Obligations of the Management Company. 
 (a) Use and Disclosure of Protected Health Information. The Management Company
may use and disclose PHI as permitted or required under this Agreement (including this Exhibit B) or as Required by Law, but may not otherwise use or disclose any PHI. The Management Company will not, and will assure that its employees, other
agents and contractors do not use or disclose PHI in any manner that would constitute a violation of HIPAA if so used or disclosed by the Company. Without limiting the generality of the foregoing, the Management Company is permitted to use or
disclose PHI as set forth below: 
 (i) The Management Company may use PHI internally for the Management Company’s proper management
and administration or to carry out its legal responsibilities. 

 (ii) The Management Company may disclose PHI to a third party for the Management
Company’s proper management and administration, provided that the disclosure is Required by Law or the Management Company obtains reasonable assurances from the third party to whom such PHI is to be disclosed that the third party will
(A) protect the confidentially of the PHI, (B) only use or further disclose the PHI as Required by Law or for the purpose for which the PHI was disclosed to the third party, and (C) notify the Management Company of any instances of
which such third-party is aware in which the confidentiality of the PHI has been breached. 
 (iii) The Management Company may use PHI to
provide Data Aggregation services relating to the Health Care Operations of the Company if required or permitted under this Agreement. 

(iv) The Management Company may de-identify PHI consistent with applicable HIPAA requirements. 

(b) Safeguards. The Management Company will use appropriate safeguards to prevent the use or disclosure of PHI other than as
permitted or required by this Exhibit B. The Management Company will implement Administrative Safeguards, Physical Safeguards and Technical Safeguards that reasonably and appropriately protect the Confidentiality, Integrity and Availability
of electronic PHI that it creates, receives, maintains or transmits on behalf of the Company. 
 (c) Minimum Necessary
Standard. To the extent required by the “minimum necessary” requirements of HIPAA, the Management Company will only request, use and disclose the minimum amount of PHI necessary to accomplish the purpose of the request, use or
disclosure. 
 (d) Mitigation. The Management Company will take reasonable steps to mitigate, to the extent practicable, any
harmful effect (that is known to the Management Company) of a use or disclosure of PHI by the Management Company in violation of this Exhibit B. 

(e) Trading Partner Agreement. The Management Company will not change the definition, Data Condition, or use of a Data Element or
Segment in a Standard; add any Data Elements or Segments to the maximum defined Data Set; use any code or Data Elements that are either marked “not used” in the Standard’s Implementation Specification or are not in the Standard’s
Implementation Specification(s); or change the meaning or intent of the Standard’s Implementation Specification(s). 
 (f)
Agreements by Third Parties. The Management Company will obtain and maintain an agreement with each agent or subcontractor that has or will have access to PHI, pursuant to which such agent or subcontractor agrees to be bound by the same
restrictions, terms and conditions that apply to the Management Company pursuant to this Agreement with respect to such PHI. 

 (g) Reporting of Improper Disclosures of PHI. 

(i) If the Management Company becomes aware of a use or disclosure of PHI in violation of this Agreement by the Management Company or a third
party to which the Management Company disclosed PHI, then the Management Company will report the use or disclosure to the Company without unreasonable delay. 

(ii) Any actual, successful Security Incident involving PHI of which the Management Company becomes aware must be reported to the Company in
writing without unreasonable delay, and 
 (iii) any attempted, unsuccessful Security Incident involving PHI of which the Management Company
becomes aware must be reported to the Company within a reasonable time. If the HIPAA security regulations are amended to remove the requirement to report unsuccessful attempts at unauthorized access, the preceding requirement to report such
unsuccessful attempts will no longer apply as of the effective date of the amendment. 
 (h) The Management Company will, following
the discovery of a Breach of Unsecured PHI, notify the Company of the Breach in accordance with 45 C.F.R. § 164.410 without unreasonable delay (and in any event within 60 days after discovery of the Breach). 

(i) Access to Information. Within 15 Business Days after receipt of a request from the Company for access to PHI about an
Individual contained in any Designated Record Set of the Company maintained by the Management Company, the Management Company will make available to the Company such PHI for so long as the Management Company maintains such information in the
Designated Record Set. If the Management Company receives a request for access to PHI directly from an Individual, then the Management Company will forward such request to the Company within 10 Business Days. 

(j) Availability of PHI for Amendment. Within 15 Business Days after receipt of a request from the Company for the amendment of
an Individual’s PHI contained in any Designated Record Set of the Company maintained by the Management Company, the Management Company will provide such information to the Company for amendment and incorporate any such amendments in the PHI
(for so long as the Management Company maintain such information in the Designated Record Set) as required by 45 C.F.R. § 164.526. If the Management Company receives a request for amendment to PHI directly from an Individual, then the
Management Company will forward such request to the Company within 10 Business Days. 
 (k) Accounting of Disclosures. Within
15 Business Days after receipt of notice from the Company stating the Company has received a request for an accounting of disclosures of PHI (other than disclosures to which an exception to the accounting requirement applies), the Management Company
will make available to the Company such information as is in the Management Company’s possession and required for the Company to make the accounting required by 45 C.F.R. § 164.528. 

(l) Availability of Books and Records. The Management Company will make its internal practices, books and records relating to the
use and disclosure of PHI available 

 
to the Secretary for purposes of determining the Company’s and the Management Company’s compliance with HIPAA. 

3. Obligations of Company. 

(a) Permissible Requests. The Company will not request that the Management Company use or disclose PHI in any manner that would
not be permissible under HIPAA if done directly by the Company. 
 (b) Minimum Necessary Information. The Company represents
that, to the extent the Company provides PHI to the Management Company, such information is the minimum necessary PHI for the accomplishment of the Management Company’s purpose. 

(c) Consents/Authorizations. The Company represents that, to the extent the Company provides PHI to the Management Company, the
Company has obtained the consents, authorizations and other forms of legal permission required under HIPAA and other applicable Law, including any necessary authorizations for the use of PHI for Marketing purposes, if applicable. 

4. Termination of this Agreement. 

(a) Right to Report. If termination of this Agreement is not feasible following the Management Company’s failure to cure a
material breach of this Exhibit B, then the Company may report such breach to the Secretary. 
 (b) Return or Destruction of
PHI. Promptly after the expiration or termination of this Agreement, the Management Company will either return to the Company or destroy, delete or erase all PHI then in the Management Company’s possession; provided, however, that to
the extent that the Management Company reasonably determines that the return or destruction of such PHI is not feasible, then the terms and provisions of this Exhibit B will survive the expiration or termination of this Agreement and such PHI
may be used or disclosed only for the purposes that prevented the Management Company’s return or destruction of such PHI.EX-10.25

 Exhibit 10.25 

NOMINEE AGREEMENT 
 THIS NOMINEE
AGREEMENT (the “Agreement”) is entered into as of June 8, 2015, by and among Avero Laboratory Holdings, LLC, a Delaware limited liability company (“Avero”), Mattison Pathology, LLP d/b/a Avero Diagnostics,
a Texas limited liability partnership (the “Company”), Thomas R. Mattison, M.D., P.A., Michael T. Mattison, M.D., P.A., and Tanner L. Mattison, M.D., P.A., each a Texas professional association (each, a “Practice”
and collectively, the “Practices”), and Thomas R. Mattison, M.D., Michael T. Mattison, M.D., and Tanner L. Mattison, M.D., each a resident of the State of Texas (each, an “Owner” and collectively, the
“Owners”). The Practices and the Owners may each be referred to as an “Owner Party” and collectively as the “Owner Parties.” Avero, the Company and the Owner Parties may each be referred to as a
“Party” and collectively as the “Parties.” 
 WHEREAS, the Practices own all of the issued and
outstanding limited liability partnership interests of the Company (the “Interests”), and the Owners own all of the issued and outstanding capital stock or other equity interests of the Practices (the “Practice Equity
Interests”); 
 WHEREAS, the Parties have entered into that certain Purchase Agreement (the “Purchase
Agreement”) and the Company and Avero have entered into that certain Management Agreement (the “Management Agreement”), each dated as of the date hereof; and 

WHEREAS, the Owner Parties’ strict compliance with the terms hereof is an essential component of Avero receiving the
benefits it bargained for under the Purchase Agreement and the Management Agreement; 
 NOW, THEREFORE, in consideration of the
foregoing premises and the mutual benefits to be derived hereby, and the premises, representations, warranties, covenants and agreements herein contained, and other good and valuable consideration, the Parties hereby agree as follows: 

1. Restricted Securities. The restrictions contained in this Agreement will apply to the Interests and any new, substituted or
additional securities of the Company issued to any Owner Party with respect to the Interests or other securities or property of the Company distributed to any Owner Party with respect to the Interests upon any stock dividend, stock split, reverse
stock split, recapitalization, merger, reorganization or other change affecting the Company’s outstanding equity securities (collectively, the “Restricted Securities”). 

2. Covenants. 

(a) Except as otherwise provided in this Agreement, neither the Practices nor the Owners shall, and the Owners shall cause the
Practices not to, directly or indirectly (voluntarily, involuntarily or by operation of law) sell, assign, transfer, gift, pledge, hypothecate, encumber or otherwise dispose of (“Transfer”), or enter into an agreement to Transfer,
the Restricted Securities. In addition, the Owners shall not directly or indirectly Transfer, or enter into an agreement to Transfer, the Practice Equity Interests or any other 

 
equity securities of the Practices hereafter acquired by any Owner (whether by dividend, split, reverse split, recapitalization, merger, consolidation or otherwise) (the “Restricted
Practice Securities”). 
 (b) Prior to the exercise of any right to vote or grant of a consent with respect to the
Restricted Securities, the Owner Parties shall give notice to Avero of the subject of such vote or consent and shall consult with Avero with regard to the manner in which such vote will be cast or consent given. Avero will thereafter recommend a
course of action to the Owner Parties, and each Owner Party will, at the time it receives the recommendation from Avero, indicate whether it intends to act in accordance with Avero’s recommendation or whether it intends to act in a manner that
is not recommended by Avero. Should any Owner Party indicate its intent to act in a manner that is not recommended by Avero, Avero shall have the right to immediately exercise its rights pursuant to Section 3 hereof, and
such Owner Party agrees that upon Avero’s exercise of such rights, it will refrain from voting or granting consent with respect to the Restricted Securities until the Restricted Securities are transferred in accordance with
Section 3. In no event shall Avero be permitted to vote the Restricted Securities, and nothing contained herein shall be construed as a voting trust, proxy or other arrangement vesting Avero with the authority to exercise
the voting power of the Restricted Securities. Notwithstanding the foregoing, Avero shall not have any control over the manner in which either the Company or the Owner Parties engage in the practice of medicine or otherwise provide medical care.

 (c) Except as expressly authorized by Avero, the Owner Parties shall not cause the Company to make any distributions or to
pledge, assign or otherwise encumber any of its assets, except for cash distributions of the Closing Purchase Price, Escrow Funds or any Earn-Out Payment pursuant to (and as defined in) the Purchase Agreement.
The Owner Parties shall notify Avero promptly upon receipt of any information relating to any claim or lien against the Company or any of its assets or against the Owner Parties with respect to the Restricted Securities. 

(d) The Company agrees not to issue any Restricted Securities to any person or entity without the consent of Avero. The
Practices agree not to issue any Restricted Practice Securities to any person or entity other than the Owners without the consent of Avero. 

3. Transfers. 
 (a) Avero
shall have the exclusive and irrevocable right to designate a Designated Transferee to purchase and acquire from each Owner Party all of such Owner Party’s right, title and interest in the Restricted Securities at any time upon Avero’s
election in its sole discretion (an “Optional Transfer Event”). Each Owner Party hereby irrevocably and unconditionally agrees to Transfer the Restricted Securities held by such Owner Party to the Designated Transferee upon the
occurrence of an Optional Transfer Event. 

  
 2 

 (b) If an Automatic Transfer Event (as defined below) occurs, then all of the Restricted
Securities then-held by the applicable Owner Party (or any heir, executor, administrator, personal representative, estate, testamentary beneficiary, donee, trustee in bankruptcy, successor or assignee of such Owner Party) (the
“Transferor”) will immediately be deemed transferred to the Designated Transferee without action by such Transferor. 
 (c)
Upon an Optional Transfer Event or Automatic Transfer Event and in consideration for the Restricted Securities, the Designated Transferee will pay to the Transferor the aggregate consideration of One Hundred and 00/100 U.S. Dollars ($100.00) (the
“Purchase Price”), delivered in immediately available funds within thirty days after the Transfer of the Restricted Securities to the Designated Transferee. Notwithstanding the Designated Transferee’s obligation to pay the
Purchase Price to the Transferor pursuant to this Section 3(c): 
 (i) the Restricted Securities
will be immediately deemed Transferred to the Designated Transferee upon an Optional Transfer Event or Automatic Transfer Event and thereafter the Transferor will only have the right to receive the Purchase Price from the Designated Transferee; 

(ii) neither the Transferor nor any purported transferee of the Restricted Securities (other than the Designated Transferee)
will have or may exercise any voting, economic or other rights or interests in the Restricted Securities or otherwise with respect to the Company; and 

(iii) the Transferor (including the related Owner) will automatically and immediately be deemed to have resigned from all
director, manager and officer positions of the Company that were held by the Transferor (including the related Owner) upon the occurrence of the Optional Transfer Event or Automatic Transfer Event. 

If the Designated Transferee fails to timely pay the Purchase Price to the Transferor in accordance with this Section 3, the
Transferor’s only remedy will be money damages and such failure will not jeopardize the Transfer of the Restricted Securities to the Designated Transferee. 

(d) Notwithstanding the self-executing provisions of Section 3(c), in the event of any Transfer, the applicable Owner
Party (or other Transferor) shall execute and deliver to Avero and the Designated Transferee all documents necessary to Transfer the Restricted Securities pursuant to Section 3 hereof, including any stock power, LLC or
partnership interest assignment documents, or consents that must be obtained, duly executed in blank with all appropriate transfer stamps affixed thereto. The Owner Parties have completed in blank the Restricted Securities Transfer Power attached
hereto as Exhibit A to facilitate the agreements set forth herein. The Owner Parties hereby acknowledge and agree that the Designated Transferee shall, for all purposes, thereafter be the record owner of all rights, title and interest in and
to the Restricted Securities. 

  
 3 

 (e) “Automatic Transfer Event” means, with respect to any Owner Party,
(i) the Owner (and with respect to each Practice, the related Owner) dies or becomes incompetent or permanently disabled, (ii) the Owner Party is disqualified from holding the Restricted Securities under applicable Law or the
Company’s governing documents, (iii) the Practice is dissolved, whether administratively or otherwise, (iv) the Owner Party attempts to Transfer any Restricted Securities or Restricted Practice Securities not in compliance with this
Agreement, (v) the Employment Agreement of even date herewith between the Owner (and with respect to each Practice, the related Owner) and the Company is terminated for any reason, (vi) the Owner Party becomes insolvent, voluntarily files
for bankruptcy or similar protection from creditors, is subject to an involuntary petition for bankruptcy or similar protection, (vii) any petition or other document is filed to cause or intended to cause a judicial, administrative, voluntary
or involuntary dissolution of the Company, (viii) any petition or other document is filed seeking judicial or administrative review of, or challenging the enforceability of this Agreement, the Company’s certificate of formation or any
other agreement, document or instrument pertaining to the governance, management or operation of the Company or (ix) the Owner’s license to practice medicine in the State of Texas is suspended, revoked or otherwise limited. 

(f) “Designated Transferee” means 

(i) in the event of an Optional Transfer Event, (A) any person designated by Avero that is entitled to hold the Restricted
Securities under the laws of the State of Texas or (B) Avero or any affiliate of Avero in the event that Avero, in its sole discretion, decides to convert the Company into a non-professional entity (even
if such conversion may require such entity to cease providing professional services in Texas); 
 (ii) in the event of an
Automatic Transfer Event, (A) the other Owner Parties, if any, that continue to hold Restricted Securities in compliance with this Agreement on the date of the Automatic Transfer Event; (B) if no other Owner Parties are eligible to receive
the transferred Restricted Securities pursuant to the foregoing, then the individual who, immediately after an Automatic Transfer Event, holds the title of Medical Director of Avero (provided that such person is a physician licensed to practice
medicine in Texas) or (C) if no such individual exists, or if Avero otherwise elects, a licensed physician designated by Avero. 
 4.
Indemnification. 
 (a) Avero agrees to indemnify and hold the Owner Parties harmless from and against any and all damage, loss,
liability, obligation, commitment, cost or expense (including the reasonable fees and expenses of counsel) incurred by the Owner Parties and resulting from or in respect of any liability (including tax liabilities) imposed upon the Owner Party as
the result of its ownership of the Restricted Securities from and after the date of this Agreement until its disposition of the Restricted Securities; provided, however, that the Owner Parties shall not be entitled to indemnification hereunder with
respect to (A) any liabilities for which Avero is entitled to indemnification from any Owner Party under the Purchase Agreement, (B) any 

  
 4 

 
liabilities, including tax liabilities, relating to periods prior to the date of this Agreement (to the extent the Owner Parties are responsible therefor under the Purchase Agreement), (C) the
provision of medical services by such Owner Party or (D) the fraud, gross negligence, willful misconduct or illegal activity of any Owner Party (for the avoidance of doubt, not including any activity contemplated by this Agreement). 

(b) Any indemnification claim under Section 4(a) of this Agreement shall be handled pursuant to Section 8.6 of the Purchase
Agreement, as if Owner Parties were the Indemnitee, and Avero was the Indemnitor. 
 (c) The Owner Parties shall not settle or compromise any
such claim without Avero’s prior written consent. 
 6. Miscellaneous. 

(a) This Agreement shall be effective immediately and shall remain in effect until the earlier of (i) the termination by the Parties,
evidenced in writing and signed by the Parties or (ii) the Transfer of the Restricted Securities pursuant to and in accordance with the terms and conditions of this Agreement. 

(b) This Agreement constitutes the entire and final agreement of the Parties with respect to the subject matter hereof, and it is hereby agreed
that any prior oral or written agreement, promise, representation, warranty, understanding or assurance expressing, concerning or relating to the matters addressed herein (excluding such other documents as may be entered into by Avero and the Owner
Parties contemporaneously herewith) are merged herein and shall be null and void and of no further force or effect. 
 (c) Each Owner Party
hereby represents and warrants that he is not a party to any other agreement, nor will it enter into any other agreement during the term of this Agreement, that is inconsistent with the terms and provisions of this Agreement. 

(d) Except as otherwise expressly provided herein, this Agreement may only be amended, terminated or modified upon the written consent of all
Parties to this Agreement. 
 (e) This Agreement shall be binding upon the Parties, and their respective heirs, administrators, executors,
personal representatives, successors and assigns, and the Parties covenant and agree that they themselves and their respective heirs, executors, successors, administrators, personal representatives and assigns will execute any and all instruments,
releases, assignments and consents that may reasonably be required of them to more fully implement the provisions of this Agreement, except that the Owner Parties may not assign this Agreement or any of their rights or obligations hereunder without
the prior written consent of Avero. Avero may assign its rights and obligations hereunder, in whole or in part, without the consent of the Owner Parties. Avero may also assign any or all of its rights, title and interest in and pursuant to this
Agreement to any of their lenders as collateral security, and 

  
 5 

 
the Owner Parties shall cooperate with any such assignment by executing such documents in connection therewith as shall be reasonably be required. 

(f) All headings set forth in this Agreement are intended for convenience only and shall not control or affect the meaning, construction,
interpretation or effect of this Agreement or of any of the provisions hereof. Any reference herein to the masculine, feminine or neuter gender shall be nonspecific in nature and shall equally apply to the appropriate gender of the party concerned.

 (g) If any provision of this Agreement shall be held to be illegal or unenforceable, such illegality or unenforceability shall extend to
that provision solely, and the remainder of this Agreement shall be enforced as if such illegal or unenforceable provision were not incorporated herein. In addition, if any portion or all of this Agreement is determined to be unenforceable, the
Parties shall revise the Agreement in a manner that complies with applicable laws and preserves the economic rights of the Parties hereunder. 

(h) The Parties acknowledge, understand and agree that the rights to purchase, own and vote, and the obligations to purchase or sell, the
Restricted Securities are unique and invaluable rights, the loss of which are not susceptible to monetary quantification. The Parties also agree that the rights and obligations provided herein are fair and equitable, were bargained for and given in
exchange for fair and adequate consideration, and are intended by the Parties to be legally enforceable in accordance with the terms set forth herein. Accordingly, the Parties hereby agree that an action for specific performance or injunctive or
other equitable relief of the rights, obligations and restrictions created by or under this Agreement is a proper and appropriate remedy for the breach of its provisions, and shall be available to the Parties, and no bond shall be required to be
posted in connection therewith. If a party to this Agreement is required to institute legal proceedings to enforce its rights, or the other party’s obligations, in accordance with the provisions of this Agreement, and such party prevails in
such legal proceedings in a binding, non-appealable final judgment, then such prevailing party shall be entitled to recover its reasonable attorneys’ fees and court costs incurred in enforcing such rights
and/or obligations. 
 (i) This Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State
of Texas. Each Party hereby irrevocably consents to the exclusive jurisdiction of the state and federal courts of the State of Texas and irrevocably agrees that all actions or proceedings relating to this Agreement shall be litigated in such courts.
Each Party waives any objection which it may have based on lack of personal jurisdiction, improper venue or forum non conveniens to the conduct of any proceeding in any such court and waives personal service of any and all process upon them. 

(j) This Agreement may be executed in separate counterparts, each of which shall serve as an original for all purposes, and all of which
together shall constitute one and the same agreement. 

  
 6 

 (k) All notices, requests, demands and other communications required or permitted hereunder
shall be in writing and shall be deemed to have been duly given when delivered by hand or mailed, first class certified mail with postage paid or by overnight receipted courier service: 

(i) If to Owner Parties, to: 

To Thomas R. Mattison, M.D., P.A. or Thomas R. Mattison, M.D.: 

4106 86th Street 

Lubbock, TX 79423 
 Attn: Thomas
Mattison 
 E-mail: trmattison@averodx.com 

with a copy to: 
 Harwell Howard
Hyne Gabbert & Manner, P.C. 
 333 Commerce St., Suite 1500 

Nashville, TN 37201 
 Attention:
David Cox 
 Facsimile: 615-251-1056 

E-mail: david.cox@h3gm.com 

To Michael T. Mattison, M.D., P.A. or Michael T. Mattison, M.D. 

2904 Bryn Mawr 
 Dallas, TX
75225 
 Attn: Trae Mattison 

Email: tmattison@averodx.com 

with a copy to: 
 Harwell Howard
Hyne Gabbert & Manner, P.C. 
 333 Commerce St., Suite 1500 

Nashville, TN 37201 
 Attention:
David Cox 
 Facsimile: 615-251-1056 

E-mail: david.cox@h3gm.com 

  
 7 

 To Tanner L. Mattison, M.D., P.A. or Tanner L. Mattison, M.D. 

2609 Sir Gawain Lane 

Lewisville, TX 75056 
 Attn:
Tanner Mattison 
 E-mail: tlmattison@averodx.com 

with a copy to: 
 Harwell Howard
Hyne Gabbert & Manner, P.C. 
 333 Commerce St., Suite 1500 

Nashville, TN 37201 
 Attention:
David Cox 
 Facsimile: 615-251-1056 

E-mail: david.cox@h3gm.com 

or to such other person or address as the Owner Parties shall furnish by notice to Avero in writing. 

(ii) If to Avero to: 

Progenity, Inc. 
 4330 La Jolla
Village Drive, Suite 200 
 San Diego, CA 92122 

Attention: CEO and General Counsel 

Facsimile: 760-268-0771 

E-mail: clarke.neumann@progenity.com 

or to such other person or address as the Avero shall furnish by notice to Owner Parties in writing. 

[Signatures on the Following Page] 

  
 8 

 IN WITNESS WHEREOF, the Parties to this Agreement, intending to be legally bound,
have hereunto set their signatures as of the date first above written. 
  

			
	AVERO:
	
	AVERO LABORATORY HOLDINGS, LLC
		
	By:	 	 /s/ Harry Stylli

		 	Harry Stylli
		 	Executive Chairman
	
	COMPANY:
	
	MATTISON PATHOLOGY, LLP
		
	By:	 	 /s/ John C. Mazzei

	Name: John C. Mazzei
	Title: C.E.O.
	
	PRACTICES:
	
	THOMAS R. MATTISON, M.D., P.A.
		
	By:	 	 /s/ Thomas R. Mattison

		 	Thomas R. Mattison, M.D.
		 	President
	
	MICHAEL T. MATTISON, M.D., P.A.
		
	By:	 	 /s/ Michael T. Mattison

		 	Michael T. Mattison, M.D.
		 	President

  

  
 [Signature Page to
Nominee Agreement] 

 
			
	TANNER L. MATTISON, M.D., P.A.
		
	By:	 	 /s/ Tanner L. Mattison; President

		 	Tanner L. Mattison, M.D.
		 	President
	
	OWNERS:
		
		 	 /s/ Thomas R. Mattison

		 	Thomas R. Mattison, M.D.
		
		 	 /s/ Michael T. Mattison

		 	Michael T. Mattison, M.D.
		
		 	 /s/ Tanner L. Mattison, M.D.

		 	Tanner L. Mattison, M.D.

  
 [Signature Page to
Nominee Agreement] 

 Exhibit A 

Restricted Securities Transfer Power 

 RESTRICTED SECURITIES TRANSFER POWER 

(Separate from Certificate) 
 FOR VALUE
RECEIVED, the undersigned does hereby (i) sell, assign, transfer and deliver to _________________________________ _____________________________ all of the limited liability partnership interests and other equity securities of Mattison
Pathology, LLP d/b/a Avero Diagnostics, a Texas limited liability partnership (the “Company”), standing in my name on the books and records of the Company and (ii) irrevocably constitute Avero Laboratory Holdings, LLC as my
attorney to transfer such equity securities on the books of the Company with full power of substitution in the premises 
  

	
	Date: ______________________
	
	By: _______________________
	Name:
	Title:
	
	Witnessed by:
	
	__________________________
	Name:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}]]